LivaNova (LIVN) Capital Expenditures (2015 - 2026)
LivaNova's (LIVN) quarterly Capital Expenditures came in at $31.6 million in Q2 2026, up 108.29% year-over-year from $15.1 million in Q2 2025, and up 120.78% quarter-over-quarter from $14.3 million in Q1 2026.
Analysis
LivaNova (LIVN) Capital Expenditures (2015 - 2026) Analysis & Trends
LivaNova has disclosed Capital Expenditures across 12 years of filings, most recently posting $31.6 million for Q2 2026.
- In Q2 2026, Capital Expenditures rose 108.29% year-over-year to $31.6 million; the TTM figure through Jun 2026 stood at $101.0 million (up 85.27% YoY), while the FY2025 annual figure was $81.0 million, up 72.06% from the prior year.
- Capital Expenditures came in at $31.6 million for Q2 2026 at LivaNova, up from $14.3 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $32.2 million in Q4 2025 to a low of $5.2 million in Q1 2022.
- Average Capital Expenditures over 5 years is $13.1 million, with a median of $10.6 million recorded in 2024.
- Year-over-year, Capital Expenditures tumbled 36.56% in 2022 and surged 209.75% in 2025.
- Over 5 years, Capital Expenditures stood at $9.1 million in 2022, then jumped by 41.44% to $12.9 million in 2023, then fell by 19.45% to $10.4 million in 2024, then surged by 209.75% to $32.2 million in 2025, then slipped by 2.12% to $31.6 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $31.6 million in Q2 2026, $14.3 million in Q1 2026, and $32.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 87.50 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 31.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.55 Mn |
| Mar 31, 2026 | 14.29 Mn |
| Dec 31, 2025 | 32.23 Mn |
| Sep 30, 2025 | 22.88 Mn |
| Jun 30, 2025 | 15.15 Mn |
| Mar 31, 2025 | 10.79 Mn |
| Dec 31, 2024 | 10.41 Mn |
| Sep 30, 2024 | 18.15 Mn |
| Jun 30, 2024 | 12.16 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Dec 31, 2023 | 12.92 Mn |
| Sep 30, 2023 | 8.72 Mn |
| Jun 30, 2023 | 5.66 Mn |
| Mar 31, 2023 | 7.69 Mn |
| Dec 31, 2022 | 9.13 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 6.13 Mn |
| Mar 31, 2022 | 5.22 Mn |
| Dec 31, 2021 | 7.59 Mn |
| Sep 30, 2021 | 3.27 Mn |